tirzepatide とは チルゼパチド（マンジャロ／ゼップバウンド）｜週1回注射の選び方（糖尿病／肥満症） 肥満および糖尿病前科の患者に対する3年間の研究では、tirzepatideの効果はかなり大きく、持続的な減量効果があり、tirzepatideと 同様の処方物質とは比較して糖尿病の進行リスクが低下しました。SURMOUNT-1の完全な実験結果と研究要約: https://nej.md/48VdDZp 内分泌学

It may be especially beneficial for people with weight-related conditions such as type 2 diabetes, high blood pressure, or high cholesterol

Discover how Epitalon supports telomeres, sleep, immunity, and cellular longevity

How is This Medication Taken

The [growth differentiation factor] thats most important is called myostatin

Tirzepatide is the first in its class, being a single-molecule agonist of both the GLP-1 receptor and the receptor for glucose-dependent insulinotropic polypeptide (GIP), hence the term dual agonist or twincretin

This dual agonist approach helps to regulate blood glucose levels by enhancing insulin secretion in a glucose-dependent manner, which means it acts when blood sugar levels are high